Galapagos NV Company Information
Galapagos NV's employee growth, exchange listings and data sources
Key Information
- Name: Galapagos NV
- Ticker: GLPG
- Exchange: NasdaqGS
- Founded: 1999
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: €1.750b
- Listing Market Cap: €1.878b
- Shares Outstanding: 65.90m
- Website: https://www.glpg.com
Number of Employees
Location
- Galapagos NV
- Generaal De Wittelaan L11 A3
- Mechelen
- Antwerp
- 2800
- Belgium
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GLPG | ENXTAM (Euronext Amsterdam) | Yes | Ordinary Shares | NL | EUR | May 2005 |
| GXE | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | May 2005 |
| 0JXZ | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | EUR | May 2005 |
| GXE | XTRA (XETRA Trading Platform) | Yes | Ordinary Shares | DE | EUR | May 2005 |
| GLPG.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | May 2005 |
| GLPGA | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | EUR | May 2005 |
| GLPG | WBAG (Wiener Boerse AG) | Yes | Ordinary Shares | AT | EUR | May 2005 |
| 4GLPG | ETLX (Eurotlx) | Yes | Ordinary Shares | IT | EUR | May 2005 |
| GLPG N | BMV (Bolsa Mexicana de Valores) | Yes | Ordinary Shares | MX | MXN | May 2005 |
| GLPG | NasdaqGS (Nasdaq Global Select) | SPON ADR REPR 1 ORD SHS | US | USD | May 2008 | |
| GXEA | DB (Deutsche Boerse AG) | SPON ADR REPR 1 ORD SHS | DE | EUR | May 2008 | |
| G1LP34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 20 REPR 1 ADR | BR | BRL | Sep 2022 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/25 00:00 |
| End of Day Share Price | 2024/04/25 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.